Effect of soluble products from lectin-stimulated lymphocytes on the growth, adhesiveness, and glycosaminoglycan synthesis of cultured synovial fibroblastic cells.

Human blood mononuclear cells exposed to concanavalin A or phytohemagglutinin secrete a soluble factor that arrests the growth of human synovial fibroblastic cells in culture. Once the growth-inhibitory effect is initiated it cannot be reversed by washing the fibroblastic cells, by refeeding with nonconditioned fresh serum-containing medium, by trypsinization, EDTA treatment, or a combination of these procedures. Media from nonstimulated mononuclear cells, fibroblastic cells, or the lectins themselves do not contain similar inhibitory activity that can be detected by the present culture systems. This lectin-dependent, growth-inhibitory activity does not have a cytotoxic effect on the fibroblasts but increases their adhesiveness to plastic or glass surfaces, and the cells tend to assume a less fibroblastic morphology. The growth-inhibitory activity is stable in the cold and is nondialyzable or ultrafilterable, but the activity is rapidly lost at temperature between 60 degrees and 70 degrees C and at pH 2.0. The growth-arrested cells secrete more glycosaminoglycan per cell in the medium and synthesize more cell surface glycosaminoglycan than the controls. However, the increased glycosaminoglycan synthesis cannot be explained as being entirely secondary to a cell density effect as it is also observed when adjustments are made for the differences in growth rates.

[1]  T. Anastassiades,et al.  The growth kinetics of synovial fibroblastic cells from inflammatory and noninflammatory arthropathies. , 1978, Arthritis and rheumatism.

[2]  Ritchie Jc,et al.  Connective tissue activation. XI. Stimulation of glycosaminoglycan and DNA formation by a platelet factor. , 1977 .

[3]  G. Granger,et al.  Identification of multiple cytolytic components associated with the beta-LT class of lymphotoxins released by mitogen-activity human lymphocytes in vitro. , 1976, Journal of immunology.

[4]  T. Anastassiades,et al.  Possible limitation of growth in human fibroblast cultures by diffusion , 1975, Journal of cellular physiology.

[5]  D. Gospodarowicz Purification of a fibroblast growth factor from bovine pituitary. , 1975, The Journal of biological chemistry.

[6]  T. Anastassiades,et al.  Role of pH in fibroblast proliferation , 1974, Journal of cellular physiology.

[7]  A. Badger,et al.  The production of proliferation inhibitory factor (pif) by mouse spleen cells in vitro. , 1974, Journal of Immunology.

[8]  E. Froesch,et al.  Fibroblasts as an Experimental Tool in Metabolic and Hormone Studies , 1973, European journal of clinical investigation.

[9]  M. Ziff Pathophysiology of rheumatoid arthritis. , 1973, Federation proceedings.

[10]  J. Peter,et al.  Target cell lysis mediated by soluble cytotoxin released from stimulated lymphocytes. , 1971, Nature: New biology.

[11]  S. Cooperband,et al.  Inhibition of target cell proliferation by supernatants from cultures of human peripheral lymphocytes. , 1970, Journal of immunology.

[12]  G. Granger,et al.  Lymphocyte in vitro cytotoxicity: correlation of derepression with release of lymphotoxin from human lymphocytes. , 1969, Journal of immunology.

[13]  G. Granger,et al.  Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Z. J. Lucas,et al.  Cytotoxic activity of lymphocytes. VII. cellular origin of alpha-lymphotoxin. , 1978, Journal of Immunology.